Author: admin

  • Aon Signs Definitive Agreement to Sell Significant Majority of NFP’s Wealth Business to Madison Dearborn Partners

    Aon Signs Definitive Agreement to Sell Significant Majority of NFP’s Wealth Business to Madison Dearborn Partners

    Aon Signs Definitive Agreement to Sell Significant Majority of NFP’s Wealth Business to Madison Dearborn Partners

    –       The agreement includes Wealthspire Advisors, Fiducient Advisors, Newport Private Wealth and related platforms 
    –       Transaction reinforces Aon’s focus on core Risk Capital and Human Capital capabilities and presence in the middle market
    –       Madison Dearborn Partners to support further growth of businesses to meet evolving client needs
    –       Purchase price estimated to be $2.7 billion at time of close, which is expected in Q4 2025

    DUBLIN and CHICAGO, Sept. 3, 2025 /PRNewswire/ — Aon plc (NYSE: AON), a leading global professional services firm, today announced that it has signed a definitive agreement to sell a significant majority of NFP’s wealth business – Wealthspire Advisors, Fiducient Advisors, Newport Private Wealth and related platforms – to Madison Dearborn Partners, LLC (“MDP”), a leading private equity investment firm based in Chicago.

    “With our 3×3 Plan to accelerate our Aon United strategy, we are more focused than ever on serving our clients’ risk and people needs with distinction,” said Greg Case, CEO of Aon. “This transaction reinforces our ongoing commitment to investing in and growing our core Risk Capital and Human Capital capabilities. Through disciplined portfolio management, we are further strengthening our capital position while enabling greater flexibility for high-return growth investments that drive sustained value creation and shareholder returns.”

    Case added: “We remain highly committed to our core wealth and retirement business helping employers, fiduciaries and investment officers through our leading institutional retirement, investment consulting and delegated management capabilities and expertise.”

    “For more than twenty years, we have successfully generated value for our portfolio companies in the financial services sector and are tremendously excited to welcome these outstanding businesses back to MDP,” said Vahe Dombalagian, Managing Partner and Co-Head of Financial Services at MDP, who led the transaction alongside Matt Raino, Partner and Co-Head of Financial Services at MDP. “Aon and NFP have been great partners and we’re pleased to deepen our relationship through this transaction.”

    Following the close of the transaction, the MDP-acquired businesses will be consolidated and operate under a unified brand name. The company will be led by Michael LaMena (currently CEO of Wealthspire Advisors) as CEO and Carl Nelson (currently Head of M&A for NFP) as President.

    “With MDP’s support, these companies will continue to thrive, working together to grow organically and through acquisitions, enhance the value they deliver to clients and create new opportunities for employee development,” said Doug Hammond, CEO of NFP. “We look forward to continuing to accelerate growth in our middle market-focused businesses by helping clients overcome challenges and meet their goals.”

    Under the terms of the transaction, MDP will acquire the businesses for a total consideration estimated to be $2.7 billion at the time of close, resulting in total after-tax cash proceeds of approximately $2.2 billion. The businesses represent approximately $127 million in EBITDA for the trailing twelve-month period ending June 30, 2025. The transaction is expected to close in late Q4 2025, subject to the satisfaction of customary closing conditions, including receipt of regulatory approvals. Given the expected timing of the close, the financial impact to Aon’s full-year 2025 results is not expected to be material.

    Advisors
    UBS Investment Bank served as lead financial advisor and Moelis & Company LLC served as financial advisor to Aon on the transaction. Skadden, Arps, Slate, Meagher & Flom LLP and Dentons acted as external legal counsel to Aon. Goldman Sachs & Co LLC acted as the financial advisor to MDP on the transaction. Paul, Weiss, Rifkind, Wharton & Garrison LLP and Kirkland & Ellis, LLP provided legal counsel to MDP.

    About Aon 
    Aon plc (NYSE: AON) exists to shape decisions for the better — to protect and enrich the lives of people around the world. Through actionable analytic insight, globally integrated Risk Capital and Human Capital expertise, and locally relevant solutions, our colleagues provide clients in over 120 countries with the clarity and confidence to make better risk and people decisions that protect and grow their businesses.

    Follow Aon on LinkedInXFacebook and Instagram. Stay up-to-date by visiting Aon’s newsroom and sign up for news alerts here.

    About NFP
    NFP, an Aon company, is an organization of consultative advisors and problem solvers helping companies and individuals address their most significant risk, workforce, wealth management and retirement challenges. With colleagues across the U.S., Puerto Rico, Canada, UK and Ireland, we serve a diversity of clients, industries and communities. Our global capabilities, specialized expertise and customized solutions span property and casualty insurance, benefits, wealth management and retirement plan advisory. Together, we put people first, prioritize partnerships and continuously advance a culture we’re proud of.

    About Madison Dearborn Partners
    Madison Dearborn Partners, LLC (“MDP”) is a leading private equity investment firm based in Chicago. Since MDP’s formation in 1992, the firm has raised aggregate capital of more than $31 billion and has completed over 160 platform investments. MDP invests across four dedicated industry verticals, including financial services, healthcare, basic industries, and technology & government. Drawing on deep industry and operational expertise, MDP works closely with management teams to drive value creation and operational improvement across its portfolio. For more information, please visit www.mdcp.com

    Media Contacts 

    Aon
    mediainquiries@aon.com
    Toll-free (U.S., Canada and Puerto Rico): +1 833 751 8114
    International: +1 312 381 3024

    Madison Dearborn Partners
    Deven Anand
    H/Advisors Abernathy
    abmacmdcp@h-advisors.global
    212.371.5999

    Safe Harbor Statement 

    This communication contains certain statements related to future results, or states Aon’s intentions, beliefs and expectations or predictions for the future, all of which are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from either historical or anticipated results depending on a variety of factors. These forward-looking statements include information about possible or assumed future results of Aon’s operations. All statements, other than statements of historical facts, that address activities, events or developments that Aon expects or anticipates may occur in the future, including, without limitation, statements about the anticipated benefits of the transaction, estimated purchase price, financial impact to Aon and Aon’s 2025 financial results, Aon’s capital position, and expected closing date are forward-looking statements. Also, when Aon uses words such as “anticipate”, “believe”, “continue”, “could”, “estimate”, “expect”, “forecast”, “intend”, “looking forward”, “may”, “might”, “plan”, “potential”, “opportunity”, “commit”, “probably”, “project”, “positioned”, “should”, “will”, “would” or similar expressions, it is making forward-looking statements. 

    The following factors, among others, could cause actual results to differ materially from those set forth in or anticipated by the forward looking statements: adverse effects on the market price of Aon’s securities and on Aon’s operating results for any reason, the failure to realize the expected benefits of the transaction, the failure to close the transaction, changes in global, political, economic, business, competitive and market forces, regulatory action, future exchange and interest rates, changes in tax laws, regulations, rates and policies, future business acquisitions or disposals, significant transaction costs or difficulties in connection with the transaction and/or unknown or inestimable liabilities, potential litigation associated with the transaction, the potential impact of the consummation of the transaction on relationships, including with suppliers, customers, employees and regulators, and general economic, business and political conditions (including any epidemic, pandemic or disease outbreak) that affect Aon. 

    Any or all of Aon’s forward-looking statements may turn out to be inaccurate, and there are no guarantees about Aon’s performance. The factors identified above are not exhaustive. Aon and its subsidiaries operate in a dynamic business environment in which new risks may emerge frequently. Accordingly, you should not place undue reliance on forward-looking statements, which speak only as of the dates on which they are made. In addition, results for prior periods are not necessarily indicative of results that may be expected for any future period. Further information concerning Aon and its businesses, including factors that could materially affect Aon’s financial results, is contained in Aon’s filings with the SEC. See Aon’s Annual Report on Form 10-K for the year ended December 31, 2024 for a further discussion of these and other risks and uncertainties applicable to Aon and its businesses. These factors may be revised or supplemented in subsequent reports filed with the SEC. Aon is not under, and expressly disclaims, any obligation to update or alter any forward-looking statement that it may make from time to time, whether as a result of new information, future events or otherwise.

    SOURCE Aon plc


    Continue Reading

  • Management of Open Tibial Fractures: Potential Treatment Recommendatio

    Management of Open Tibial Fractures: Potential Treatment Recommendatio

    1Medical School, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa; 2Department of Orthopaedic Surgery and Sports Medicine, Burjeel Hospital for Advanced Surgery, Dubai, United Arab Emirates; 3Division of Orthopaedic Surgery, Groote Schuur Hospital, Cape Town, South Africa; 4Orthopaedic Research Unit, University of Cape Town, Cape Town, South Africa; 5Department of Orthopaedic Surgery, The Royal Brisbane and Women’s Hospital, Brisbane, Australia; 6Faculty of Medicine, Biruni University, Istanbul, Turkey

    Correspondence: Erik Hohmann, Burjeel Hospital for Advanced Surgery, Dubai, United Arab Emirates, Email [email protected]

    Abstract: Treatment guidelines for open tibial fractures are well established in high-income countries, but their implementation in low-resource settings remains challenging. To date, only one African country has attempted to formulate national, consensus-based guidelines that cover key aspects such as antibiotic administration, initial stabilization, surgical debridement, wound management, and definitive fixation. This narrative review summarizes current principles for the initial management of open tibial shaft fractures and evaluates their relevance in the Southern African context, particularly in rural and resource-constrained environments. Given the limited availability of advanced imaging, specialized implants, and soft-tissue coverage expertise, clinicians must adapt existing protocols to local capacities. This review highlights areas where treatment recommendations from high-income settings may not be feasible and identifies practical considerations for applying initial management principles in Southern Africa. The need for context-specific, resource-appropriate guidelines is emphasized.

    Keywords: open tibial fractures, initial management, low-resource countries, Southern Africa, review

    Introduction

    The treatment of open tibial shaft fractures presents a significant challenge due to limited soft tissue coverage and compromised blood supply.1 Due to its close proximity to the skin, the tibia is particularly vulnerable to becoming an open fracture with significant soft tissue damage, often resulting in complications such as infection and non-union.2 The primary goals of treatment are to promote an optimal environment for fracture healing, minimize complications, and restore limb function as effectively as possible.3 Achieving these goals can pose significant challenges for both patients and healthcare systems.3

    The healthcare system in Southern Africa consists of both public and private sectors, with marked inequalities in access and quality of care.4,5 Public healthcare, largely financed by government funding, serves the majority (particularly those in rural and economically disadvantaged areas) but often suffers from resource limitations, including staff shortages, inadequate infrastructure, and irregular medication supply.4,5 In contrast, private healthcare is supported by insurance or out-of-pocket payments and delivers superior services, though it is primarily accessible to wealthier, urban populations.4,5 In South Africa, for example, a dual healthcare model exists where approximately 80% of the population depends on the public sector, while the majority of resources are concentrated in the private sector, which caters to just 20% of citizens.4,5 Therefore, the management of open fractures in low to middle-income countries of Africa presents unique challenges, including limited early access to specialist care, delays in the administration of intravenous antibiotics, difficulties with choosing appropriate methods of fixation and wound closure, as well as patients’ health-seeking behaviours prior to accessing formal orthopaedic care.6 In addition, access to healthcare remains a significant issue, particularly in rural areas outside urban centres.7

    Open fractures should be managed using a standardized care pathway that includes the prompt administration of antibiotics, surgical debridement to remove all contaminated and devitalized tissue, thorough irrigation of the wound in the operating theatre, and fracture stabilization using either internal fixation, such as intramedullary nailing, or external fixation.8–11 While these guidelines are universally applicable, their implementation may not be practical or feasible in low-income countries. The Malawi Orthopaedic Association/AO Alliance has published a national consensus statement, outlining revised standard principles that consider the country’s unique circumstances.12 The authors recommended the following procedures: adherence to ATLS principles, administration of antibiotics, assessment for neurological and vascular injuries, immediate transfer of a threatened limb to a referral hospital, preliminary realignment and splinting, formal debridement only for gross contamination, no irrigation outside the operating theatre, debridement under anaesthesia, lavage with at least 5 litres of water before draping, photographic documentation, primary closure for clean wounds, fracture stabilization using external fixation or definitive fixation if appropriate soft tissue coverage is achieved, and amputation should only be performed for life-threatening injuries.12

    The purpose of this study was to conduct a narrative review of contemporary treatments for open tibial shaft fractures and assess their applicability to the South African context.

    Methods

    This study followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines13 and the updated recommendations provided in the Cochrane Handbook.14

    Eligibility Criteria

    This project incorporated all Level I–IV evidence-based clinical studies addressing open tibial shaft fractures. Reviews, systematic reviews, and meta-analyses were excluded from the analysis; however, their references were screened to identify relevant studies meeting inclusion criteria. Abstracts and conference proceedings were also excluded from the study.

    Literature Search

    A systematic review of the literature was performed to identify all publications in English and German, screening the databases Medline, Embase, Scopus, and Google Scholar. These databases were screened using the following terms and Boolean operators: “tibial fractures” AND/OR “open” AND/OR “compound” AND/OR “tibial shaft”; AND/OR “complications” AND/OR “treatment” AND/OR “management”. For the Medline search the MeSH term “tibia” was used with the following qualifiers: “fractures, bone” and “compound fractures” One reviewer conducted independent title and abstract screening. Disagreements between reviewers were resolved by consensus, and if no consensus was reached, they were carried forward to the full-text review. All eligible articles were manually cross-referenced to ensure that other potential studies were identified. The search period was restricted to studies published between 2000 and 2025 to ensure a contemporary review of current treatment approaches for open tibial shaft fractures.

    Data Extraction and Quality Assessment

    An electronic data extraction form was employed to systematically collect information from each article, including the level of evidence, study location, patient age, and sex. The key areas documented include incidence and epidemiology, fracture classification, treatment principles, antibiotic use, debridement, surgical timing, primary skin closure, temporary wound dressings, soft tissue management, large fragment management, and the applicability of these guidelines in resource-limited settings such as Southern Africa.

    Results

    Incidence – Epidemiology

    In the United Kingdom, open fractures of the lower extremity constitute approximately 12% of all open fractures, with an estimated incidence of 3.4 cases per 100,000 individuals annually.15 These injuries demonstrate a bimodal distribution, with high-energy trauma being the predominant cause in younger populations, while low-energy trauma is more common in older individuals, often attributable to decreased bone density.15 In the Netherlands, the estimated incidence of open fractures is approximately 1.1 per 100,000 person-years, with a notable increase observed in individuals over the age of 70.16 The German Trauma Registry reported nearly 3,000 open tibial fractures within a patient cohort of 148,000 over a ten-year period.17 Weiss et al reported an annual incidence of 2.3 per 100,000 person-years for open tibial fractures in Sweden and observed a decline in the overall incidence between 1998 and 2004.18 In a 15-year study analyzing 2,386 open fractures, the authors reported that 70% occurred in males, with only 22% resulting from road traffic accidents or falls from a height.15 However, when stratified, road traffic accidents accounted for 34% of lower extremity open fractures.15

    Unfortunately, there is a lack of comprehensive data published from the African continent. Existing studies only report the total number of treated cases, without providing information on the overall trauma burden or the proportion of open fractures among admitted trauma cases. For instance, Mwafulirwa et al reported that 72 open tibial fractures were managed at a tertiary hospital in Malawi during 2019.19 Almost all of these were caused by road traffic accidents (63%), assaults (18%), and falls (17%), with males accounting for the majority of cases (82%).19 Adesina et al reported similar findings, with motorcycle riders, artisans, and farmers accounting for 63% of open fractures, of which 75% occurred in male patients.20 While Clelland et al reviewed 1016 orthopaedic inpatients admitted in Northern Tanzania, their results demonstrated 143 had open tibia fractures.21

    Classification Systems

    The two most commonly utilized classification systems for open fractures are the Gustilo-Anderson scheme21,22 and that of the Orthopaedic Trauma Association (OTA). The Gustilo-Anderson system categorizes open fractures into three grades based on wound size, extent of skin loss, and muscle damage.21,22 Generally, Type I fractures involve a clean wound less than 1 cm in length, Type II fractures feature a laceration greater than 1 cm without significant soft tissue damage, flaps, or avulsions, and Type III fractures are characterized by open segmental fractures, extensive soft tissue damage, or associated vascular injury. This classification is widely accepted due to its ability to correlate severity grades with complication rates.23 However, it has been criticized for demonstrating poor to moderate inter-observer reliability.24

    The Orthopaedic Trauma Association (OTA) classification system evaluates open fractures based on five components: skin injury, muscle injury, arterial injury, contamination, and bone loss. Each component is assessed using predefined criteria and rated on a scale from 1 (mild) to 3 (severe).25,26 Compared to the Gustilo-Anderson classification, the Orthopaedic Trauma Association system demonstrated moderate to excellent inter-observer reliability. Additionally, it has been shown to outperform the Gustilo-Anderson system in predicting post-operative complications and clinical outcomes.27 The OTA classification system was recently updated to include a category for classifying post-traumatic bone defects.28

    Although the OTA open fracture classification is more complex, it is not necessarily superior to the Gustilo-Anderson system in predicting fracture-related infections.29 Given that the Gustilo-Anderson classification is easier to remember and more widely recognized, it may be the preferred choice for assessing fracture severity in resource-limited settings such as Southern Africa.

    Principles of Treatment

    Antibiotics

    Antibiotic prophylaxis is widely recognized for reducing infection rates and particularly in preventing early infections. Mundy et al provided comprehensive recommendations for antibiotic prophylaxis in open fractures.30 For Gustilo-Anderson Type I and Type II injuries, primary coverage against gram-positive organisms is advised, typically using a first-generation cephalosporin. Prophylaxis should not extend beyond 24 hours following wound closure.30 For Type III injuries, both gram-positive and gram-negative coverage is recommended. This is achieved with a combination of a first-generation cephalosporin and an aminoglycoside. Antibiotic administration should continue for 72 hours but should not exceed 24 hours after wound closure.30 In cases of farm injuries, additional anaerobic coverage is necessary, typically using penicillin. The same timelines for antibiotic administration as those outlined for Type I–III open fractures are applicable in these cases.28 The German guidelines recommend first- or second-generation cephalosporins for Type I–III fractures, with gram-negative coverage using ampicillin/sulbactam, piperacillin, or tazobactam.10 If Clostridia is suspected, penicillin or clindamycin should be added. Antibiotic administration should begin promptly, with a duration of no more than 24 hours for Type I and II fractures, and 72 hours for Type III fractures, but no longer than 24 hours post-wound closure.10 The Orthopaedic Trauma Association (OTA) recommends using cefazolin, clindamycin, or vancomycin for Type I and II fractures, with the addition of an aminoglycoside for Type III fractures. Alternatively, a combination of piperacillin and tazobactam is suggested for Type III fractures. Importantly, antibiotics should be administered within one hour of injury, and continued for no more than 24 hours for Type I and II injuries, and 72 hours for Type III injuries.31 The current AAOS guidelines on the prevention of surgical site infection after major extremity trauma give a moderate strength of recommendation for the administration of initial and preoperative antibiotics.32

    The only guidelines established through a consensus project have been published for Malawi.12 They recommend administering intravenous antibiotics as soon as possible, ideally within one hour of presentation.12 The guidelines suggest using ceftriaxone or a combination of doxycycline and gentamicin, with the addition of metronidazole for grossly contaminated wounds.12

    The use of local antibiotics remains unclear, though it offers the potential advantage of higher antibiotic concentrations compared to intravenous delivery.33 A meta-analysis has demonstrated a 12% reduction in risk with the use of local antibiotics.34 In a systematic review and meta-analysis, Craig et al demonstrated that the local administration of antibiotics significantly reduced the incidence of infection in Grade III fractures, from 31% to 9%.35 The VANCO trial, which administered vancomycin powder directly to the fracture site, reported a 6.4% probability of deep infection by 182 days in the treatment group, compared to 9.8% in the control group, suggesting promising results.36 Pesante and Parry demonstrated that the use of vancomycin and tobramycin powder reduced the rate of deep infections following open fracture treatment, thereby confirming the findings of the VANCO trial.37 The current AAOS guidelines strongly recommend the administration of local vancomycin powder or tobramycin-impregnated beads for the prevention of surgical site infection after major extremity trauma.32

    The timing of antibiotic administration appears to be a critical factor in preventing infection. Zuelzer et al demonstrated that administering antibiotics within 150 minutes of injury significantly reduces infection risk, even after adjusting for potential confounding factors such as age, diabetes, and smoking status.38 Earlier, Patzakis and Wilkins identified timely antibiotic administration as crucial in reducing infection risk.39 In their case-control study of over 1,100 open fractures, administering antibiotics more than three hours post-injury increased the odds of infection by 1.63 times compared to treatment within the first three hours.39 Extending the duration of antibiotic prophylaxis beyond 24 hours has not demonstrated a significant benefit in reducing the risk of fracture site infections.40 In contrast, the 2017 British Orthopaedic Association recommend administering antibiotics within one hour of injury, citing a 17% reduction in infection risk compared to those receiving antibiotics after 60 minutes.41

    Antibiotic-coated nails were first described by Paley and Herzenberg for the treatment of intramedullary infections.42 However, recent studies have highlighted their potential role in the primary treatment of open tibial fractures. A recent meta-analysis, which included only two studies, indicated a trend but no statistically significant differences toward reduced infection rates with the use of antibiotic-coated nails, identifying a 17% relative risk reduction in infection.43 Similarly, De Meo et al, in a systematic review of eight studies, found no evidence of advantages associated with antibiotic-coated nails in terms of fracture-related infection, non-union, or healing in both primary and revision surgeries.44 Given the current evidence, the use of an antibiotic-coated nail for primary fracture fixation in open tibial fractures cannot be recommended. Further high-quality randomized controlled trials are needed to clarify the potential benefits of this treatment option.

    Debridement

    Debridement involves thoroughly cleaning the wound by excising necrotic and devitalized tissue and removing foreign materials. It is a critical factor in achieving optimal outcomes in the management of open tibial fractures.22 Before surgical debridement, careful wound cleansing using a soft brush and a soap solution should be considered to reduce contamination.43 Careful excision of wound margins to healthy tissue is essential; however, undermining soft tissues and preserving tenuous skin bridges should be avoided to minimize the risk of compromised healing.10 Nonviable bone fragments should be removed, and any fragments that can be easily detached without resistance (using the “tug test”) should also be excised.10 Fragments that remain attached to the periosteum, however, should be preserved.10 Contaminated bone fragments should be thoroughly cleaned, debrided, and decorticated if necessary. The routine use of a tourniquet during these procedures is generally discouraged.10 If there is uncertainty about tissue viability, a second-look debridement should be considered, particularly in cases of small wounds with significant comminution, as the initial appearance may be misleading.3

    The traditional approach of routinely debriding all open tibial fractures within 6 hours no longer appears universally applicable. The current NICE guidelines recommend immediate debridement for wounds with vascular compromise, debridement of high-energy or contaminated wounds within 12 hours, and debridement of low-energy open fractures within 48 hours.39 These recommendations align with those of other established guidelines.10,31 Interestingly, studies suggest that factors other than time to debridement play a more significant role in perioperative infection risk. Independent risk factors include smoking, diabetes, prolonged surgical time, and fracture severity. Type III injuries, in particular, are associated with higher rates of reoperation and infection.46,47

    The Malawi guidelines recommend performing debridement in the operating room under general or spinal anaesthesia.12 They advise immediate debridement for highly contaminated wounds or cases wit vascular compromise, within 12 hours for Grade II and III fractures, and within 24 hours for Grade I fractures.12

    Irrigation

    Wound irrigation is a crucial component of open tibial fracture management, effectively removing contaminants and reducing the risk of infection. Current controversies focus on the debate between high-pressure versus low-pressure lavage and the selection of the optimal irrigation fluid.

    Studies suggest that high-pressure pulsatile lavage is more effective at removing bacteria and debris compared to low-pressure lavage.48 The main concern with high-pressure lavage is the potential to push contaminants deeper into tissues, which may increase infection rates and cause further damage to soft tissues and bone.49 The FLOW trial has provided clarity, demonstrating that warm normal saline with low-pressure irrigation should be the primary and safest choice for wound lavage.50 Conversely, Omar et al concluded that there is a lack of evidence to warrant discontinuing the use of pulsatile high-pressure lavage and recommended its continued implementation.10 Regarding irrigation volume, there is general agreement that 3 litres are sufficient for Type I injuries, 6 litres for Type II, and 9 litres for Type III injuries. However, it is generally accepted that highly contaminated wounds may require larger volumes until they are adequately cleansed of contamination.10,31,41,45 Irrigation fluids containing surfactants and antiseptics are no longer recommended, as they can cause secondary injury to the wound, increasing the risk of soft tissue necrosis.10,48 Furthermore, antimicrobial agents such as bacitracin have been shown to be associated with higher rates of wound healing complications.45 The AAOS guidelines strongly recommend irrigating wounds with saline without additives for initial wound management.32

    The Malawi guidelines advise against performing washouts outside the operating room and recommend that lavage be done in conjunction with debridement.12 They suggest using at least 5 litres of tap water followed by a minimum of 2 litres of sterile fluid.12

    Timing of Surgery and Surgical Implant Options

    The treatment of open tibial fractures should adhere to the general principles of orthopaedic trauma management, and the presence of an open fracture should not justify the departure from established osteosynthesis guidelines.10 Primary treatment is largely determined by the fracture characteristics, with both internal and external fixation techniques being viable options.10,51 An exception occurs when bone defects are present, which necessitate the use of appropriate reconstruction techniques.10 In general, Type I and II open fractures can be treated primarily with definitive osteosynthesis.10,52 Most Type III injuries can also follow this approach, except in cases with large or segmental bone defects, significant soft tissue damage requiring flap coverage, severely contaminated farm injuries, or cases involving vascular injuries that necessitate urgent vascular reperfusion surgery.10,52 For primary fixation, options include intramedullary fixation, plating, and external fixation methods such as ring fixators, hexapods, and static frames.10,52 Intramedullary nailing is generally considered the primary treatment option for most open diaphyseal and extra-articular metaphyseal fractures, although alternative fixation methods may be necessary in certain cases.31 Yokohama et al demonstrated that immediate reamed or unreamed nailing for Grade 3B and 3C fractures results in higher infection rates and should be avoided.53 However, the authors also concluded that other factors, such as early debridement, timely conversion of external fixation to nailing, and prompt skin closure, are critical in reducing the risk of deep infection.53 Intramedullary nailing can also be considered to be an effective bridging device for open fractures with bone loss.31 If definitive skeletal stabilization is not feasible for any reason, temporary spanning external fixation is an effective alternative.2,10,41 Temporary external fixation should be particularly considered in cases of severe contamination, extensive soft tissue involvement, or in unstable patients.3 Furthermore, the Ganga Hospital Open Injury Score (GHOIS) can aid in decision-making, with definitive fixation typically being appropriate when the score is below 9.54 The current AAOS guidelines on preventing surgical site infections after major extremity trauma provide a moderate-strength recommendation for definitive fracture fixation at the initial debridement, along with primary wound closure when appropriate. They also suggest that temporary external fixation remains a viable option.32

    The Malawi guidelines recommend that definitive internal stabilization should only be performed when it can be immediately followed by definitive soft tissue coverage.12 They also suggest that Grade IIIA and IIIB fractures be stabilized with an external fixator at the time of debridement.12 However, no specific recommendations were made regarding other surgical fixation methods.12

    Primary Skin Closure – Temporary Wound Dressings

    Historically, immediate primary closure of open fractures was thought to increase the risk of wound infection and fracture non-union.55 However, recent published literature has challenged this long-standing assumption. Hohmann et al reported no significant difference in infection rates between patients who underwent primary closure, with an average infection rate of 4%, and those who underwent delayed closure, which had an average infection rate of 2% when primary closure was performed.56 Moola et al demonstrated that primary closure for all open fractures is safe and does not increase the risk of postoperative infection.55 Their study identified no significant correlation between fracture classification, trauma velocity, or time to wound closure and the occurrence of infection, delayed union, or non-union.50 Scharfenberger et al demonstrated that primary wound closure in Grade I–IIIA open fractures resulted in lower rates of infection (4% vs 9%) and nonunion (13% vs 29%) compared to delayed closure.57 Rajasekaran reported that primary wound closure is safe when performed under specific conditions: debridement is completed within 12 hours, there is no significant skin loss, skin approximation is achievable without tension, and there is no evidence of vascular insufficiency.54 Riechelmann et al confirmed that primary soft tissue closure is safe for Grade I–IIIA open fractures, provided that debridement is thorough, the skin margins are bleeding and viable, and appropriate antibiotics are administered.58 It is noteworthy, and perhaps counterintuitive, that re-exploration of the wound during definitive fracture fixation does not appear to be associated with an increased risk of complications.59 Reynolds et al reported no significant difference in complication rates between patients with open tibia fractures who underwent staged fixation.59

    Primary closure is generally recommended for Type I to Type IIIA tibial fractures when sufficient viable soft tissue is available to achieve tension-free closure. This approach is contingent on meticulous debridement of the injury and the timely administration of prophylactic antibiotics.60 The current AAOS guidelines on preventing surgical site infections after major extremity trauma strongly recommend the use of negative pressure therapy, as it may reduce the risk of revision surgery and superficial site infections.32 However, silver-coated dressings are generally not recommended, with only a moderate-strength recommendation.32 Regarding primary wound closure, the guidelines strongly recommend closure when feasible and when there is no significant gross contamination.32

    The Malawi guidelines recommend primary closure for clean Grade I fractures, leaving Grade II fractures open with closure within 72 hours, and keeping Grade III fractures open.12 For Grade III fractures, patients should be referred to the nearest specialized hospital for further management.12

    Soft Tissue Management

    For fracture wounds that cannot be closed primarily and may require flap coverage, the injury location, defect size, and zone of damage must be carefully assessed to determine whether rotational or free flap coverage is the most suitable option.30 Fractures in the proximal two-thirds of the tibia are typically treated with rotational muscle flaps, while those in the distal third generally require free flaps.30 Soft tissue management should aim to achieve flap coverage within 72 hours to minimize the risk of deep infection.10 Lack et al reported that delaying soft tissue closure beyond 5 days doubles the infection rate.61

    In cases where primary wound closure is not possible and temporary wound management is needed, negative pressure wound therapy is an effective option.10 Kim and Lee demonstrated in a meta-analysis that negative pressure wound therapy, compared to conventional management, resulted in lower rates of soft tissue infections, non-union, flap necrosis, and the need for revisions.62 Stannard et al reported in a randomized controlled trial that negative pressure wound therapy significantly reduced the total infection rate (acute and late combined) compared to saline-soaked dressings, although the estimate lacked precision.63 In a similar study, Kumaar et al demonstrated that negative pressure wound therapy significantly reduced infections and enhanced the healing of open fracture wounds.64 However, both the WHIST and WOLLF trials found no evidence that negative pressure wound therapy (NPWT) reduced infection rates compared to open solid foam or gauze dressings.65,66 However, the WOLLF trial was conducted in the UK, and all open fractures in their cohort underwent definitive soft tissue management within 72 hrs from injury, perhaps negating any benefit NPWT may have provided. Regardless of the wound management method, five-year results from the WHIST trial still reported high levels of persistent disability and reduced quality of life, with minimal evidence of improvement over this period.67 The current AAOS guidelines on preventing surgical site infections after major extremity trauma provide a moderate-strength recommendation for wound closure within seven days.30 However, they note that the current evidence supporting the use of an orthoplastic team or hyperbaric oxygen therapy is limited.32

    Large Bone Fragments

    The presence of large bone fragments, whether devitalized, extruded, or attached to viable soft tissue, remains a significant challenge and a subject of ongoing debate.68 Traditionally, the standard approach has been to discard devitalized or extruded cortical fragments; however, this practice has recently been questioned. In cases of severe contamination or comminution, such as ballistic injuries, retaining bone fragments is not feasible, and discarding them may be the most logical and often only option for the surgeon.68 If large bone fragments remain attached to the periosteum or pass the tug test (showing substantial resistance when attempting to remove them), they may be preserved and reduced if possible.10 Devitalized and extruded fragments can be retained if thoroughly debrided and disinfected to reduce bacterial load before being incorporated into the fracture site.69 Mechanical scrubbing followed by a five-minute immersion in povidone-iodine or chlorhexidine appears to be a safe and effective time interval.70 Another author has suggested soaking the fragment in a vancomycin solution for an additional thirty minutes to further reduce the risk of infection.71 The Bristol experience demonstrated that incorporating mechanically relevant, debrided devitalized bone fragments into the definitive reconstruction of Type IIIB open diaphyseal tibial fractures is a safe approach.69 In addition, two case reports demonstrated the successful reimplantation of extruded bone fragments.71,72

    Conclusions

    The initial treatment of open tibial fractures remains controversial and lacks robust recommendations. Key steps include early administration of intravenous antibiotics, timely debridement and lavage of open wounds, primary wound closure when tissue is viable and closure can be achieved without tension, and early flap coverage within 72 hours if needed. Preferred definitive stabilization for Grade I–IIIa fractures is intra-medullary nailing, with temporary external fixation used when necessary. Early conversion to definitive treatment is also essential.

    In low-resource countries in Southern Africa, only one guideline has been developed, which recommends the administration of early intravenous antibiotics, timely debridement and irrigation in the operating room, and management based on fracture severity. The guideline advises primary closure for Grade 1 fractures, delayed closure for Grade 2 fractures, and no closure for Grade 3 fractures, with referral to a specialist hospital for further management of Grade 3 injuries. In this context, further exploration is needed regarding the applicability of early simple oral antibiotics as an alternative to intravenous administration, the use of locally administered antibiotics, and temporary fixation with homemade antibiotic nails. Furthermore, optimal timing for both initial and definitive surgery, the use of temporary or permanent wound dressings, and soft tissue management when referral is not possible or significantly delayed require further investigation. The management of large bone fragments at the time of debridement also warrants further investigation.

    Ultimately, the absence of general recommendations and context-specific guidelines for the initial management of open tibial fractures in Southern Africa highlights the need for further work. Specific issues to address include how to evaluate and treat these injuries in low-resource settings that are by staff shortages, inadequate infrastructure, and inconsistent medication supply.

    Author Contributions

    All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis, and interpretation, or in all these areas; took part in drafting, revising, or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

    Funding

    This research did not receive any funding.

    Disclosure

    Professor Kevin Tetsworth is an unpaid consultant for AO Foundation, personal fees for speakers bureau and design consultant from Smith and Nephew, personal fees for speakers bureau from Johnson and Johnson MedTech, scientific advisory board for and shares and stock options from OrthoDx and VitaClot Medical, outside the submitted work. The authors report no other conflicts of interest in this work.

    References

    1. Qian S, Shen Y, Sun L, Wang Z. Treatment preferences and current practices regarding open tibial fractures. Front Public Health. 2024;12:1331654. doi:10.3389/fpubh.2024.1331654

    2. Nicolaides M, Pafitanis G, Vris A. Open tibial fractures: an overview. J Clin Orthop Trauma. 2021;20:101483. doi:10.3389/fpubh.2024.1331654

    3. Dheenadhaylan J, Nagashree V, Devendra A, Velmurugesan PS, Rajasekaran S. Management of open fractures: a narrative review. J Clin Orthop Trauma. 2023;44:102246. doi:10.1016/j.jcot.2023.102246

    4. Ataguba JE, McIntyre D. Paying for and receiving benefits from health services in South Africa: is the health system equitable? Health Policy Plan. 2012;27(1):i35–45. doi:10.1093/heapol/czs005

    5. Coovadia H, Jewkes R, Barron P, Sanders D, McIntyre D. The health and health system of South Africa: historical roots of current public health challenges. Lancet. 2009;374(9692):817–834. doi:10.1016/S0140-6736(09)60951-X

    6. Zubair AA, Abdullateef R, Davis S, et al. A scoping review on the management of open fractures in African trauma and orthopaedics centres. Cureus. 2024;16(9):368925. doi:10.7759/cureus.68925

    7. Schade AT, Sabawo M, Nyamulani N, et al. Functional outcomes and quality of life at 1-year follow-up after an open tibia fracture in Malawi: a multicentre, prospective cohort study. Lancet Global Health. 2023;11(10):e1609–e1618. doi:10.1016/S2214-109X(23)00346-7

    8. Shafiq B, Hacquebord J, Wright DJ, Gupta R. Modern principles of acute surgical management of open tibial distal fractures. J Am Acad Orthop Surg. 2021;29(11):e536–e547. doi:10.5435/JAAOS-D-20-00502

    9. Hohmann E, Birkholtz F, Glatt V, Tetsworth K. The “road to union” protocol for the reconstruction of isolated complex high-energy tibial trauma. Injury. 2017;48(6):1211–1216. doi:10.1016/j.injury.2017.03.018

    10. Omar M, Zeckey C, Krettek C, Graulich T. Open fractures. Unfallchirurg. 2021;124(8):651–665. doi:10.1007/s00113-021-01042-2

    11. Castillo IA, Heiner JA, Meremikwu RI, Kellam J, Warner SJ. Where are we in 2022? A summary of 11,000 open tibia fractures over 4 decades. J Orthop Trauma. 2023;37(8):e326–e334. doi:10.1097/BOT.0000000000002602

    12. Schade AT, Yesaya M, Bates J, Martin Jr C, Harrison WJ. The Malawi Orthopaedic Association/AO alliance guidelines and standards for open fracture management in Malawi: a national consensus statement. Malawi Med J. 2020;32(3):112–118. doi:10.4314/mmj.v32i3.2

    13. Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic reviews and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. doi:10.1186/2046-4053-4-1

    14. Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted symptomatic reviews of the Cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev. 2019;10:ED000142. doi:10.1002/14651858.ED000142

    15. Court-Brown CM, Burgler KE, Clement ND, Duckworth AD, McQueen MM. The epidemiology of open fractures in adults. A 15-year review. Injury. 2012;43(6):891–897. doi:10.1016/j.injury.2011.12.007

    16. Noorlander-Borgdorff MP, Sekercan A, Young-Afat DA, Bouman M, Botman M, Giannakopoulos GF. Nationwide study on open tibial fractures in the Netherlands: incidence, demographics and level of hospital care. Injury. 2024;55(6):111487. doi:10.1016/j.injury.2024.111487

    17. Weber CD, Hildebrand F, Kobbe P, et al. Epidemiology of open tibia fractures in a population-based database: update on current risk factors and clinical implications. Eur J Trauma Emerg Surg. 2019;45(3):445–453. doi:10.1007/s00068-018-0916-9

    18. Weiss RJ, Montgomery SM, Ehlin A, Al Dabbagh Z, Stark A, Jansson K-A. Decreasing incidence of tibial shaft fractures between 1998 and 2004: information based on 10,627 Swedish inpatients. Acta Orthop. 2008;79(4):526–533. doi:10.1080/17453670710015535

    19. Mwafulirwa K, Munthali R, Ghosten I, Schade A. Epidemiology of open tibia fractures presenting to a tertiary hospital in Southern Malawi: a retrospective study. Malawi Med J. 2022;34(2):118–122. doi:10.4314/mmj.v34i2.7

    20. Adesina SA, Amole IO, Owolabi JI, Oyewusi OO, Adefokun IG, Eyesan SU. Locked intramedullary nailing of open fractures in resource-poor settings: a prospective observational study of challenges and functional outcomes in 101 fractures at Ogbomoso, Nigeria. BMC Musculoskelet Disord. 2023;24(1):170. doi:10.1186/s12891-023-06271-7

    21. Clelland SJ, Chauhan P, Mandari FN. The epidemiology and management of tibia and fibula fractures at Kilimanjaro Christian Medical Centre (KCMC) in Northern Tanzania. Pan Afr Med J. 2016;25:51. doi:10.11604/pamj.2016.25.51.10612

    22. Gustilo RB, Anderson JT. Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses. J Bone Joint Surg Am. 1976;58(4):453–458.

    23. Gustilo RB, Mendoza RM, Williams DN. Problems in the management of type III (severe) open fractures: a new classification of type III open fractures. J Trauma. 1984;24(8):742–746. doi:10.1097/00005373-198408000-00009

    24. Thakore RV, Francois EL, Nwosu SK, et al. The Gustilo-Anderson classification system as predictor of nonunion and infection in open tibia fractures. Eur J Trauma Emerg Surg. 2017;43(5):651–656. doi:10.1007/s00068-016-0725-y

    25. Brumback RJ, Jones AL. Interobserver agreement the classification of open fractures of the tibia. The results of a survey of two hundred and forty-five orthopaedic surgeons. J Bone Joint Am. 1994;76(8):1162–1166. doi:10.2106/00004623-199408000-00006

    26. Orthopaedic Trauma Association: Open Fracture Study Group. A new classification system scheme for open fractures. J Orthop Trauma. https://ota.org/sites/files/2021-06/General%20B2%20Open%20Fractures.pdf. 2010;24(8):457–464. doi:10.1097/BOT.0b013e3181c7cb6b

    27. Hao J, Cuellar DO, Herbert B, et al. oes the OTA Open Fracture Classification Predict the Need for Limb Amputation? A Retrospective Observational Cohort Study on 512 Patients. J Orthop Trauma. 2016;30(4):194–198. doi:10.1097/BOT.0000000000000479

    28. Tetsworth KD, Burnand HG, Hohmann E, Glatt V. Classification of Bone Defects: An Extension of the Orthopaedic Trauma Association Open Fracture Classification. J Orthop Trauma. 2021;35(2):71–76. doi:10.1097/BOT.0000000000001896

    29. Khoury P, Hazra N, DeMartino A, et al. Is the Orthopaedic Trauma Association-Open Fracture Classification Better Than the Gustilo-Anderson Classification at Predicting Fracture-Related Infections in the Tibia? J Orthop Trauma. 2024;38(1):655–660. doi:10.1097/BOT.0000000000002907

    30. Mundy R, Chaudry H, Niroopan G, Petrisor B, Bhandari M. Open tibial fractures: updated guidelines for management. JBJS Rev. 2015;3(2):e1. doi:10.2106/JBJS.RVW.N.00051

    31. Orthopaedic Trauma Association. Open Fractures. https://ota.org/sites/files/2021-06/General%20B2%20Open%20Fractures.pdf. Accessed 7, Jan 2025.

    32. Goldman AH, Tetsworth K. AAOS Clinical Practice Guideline Summary: prevention of Surgical Site Infection After Major Extremity Trauma. J Am Acad Orthop Surg. 2023;31(1):e1–e8. doi:10.5435/JAAOS-D-22-00792

    33. Flores MJ, Brown KE, Morshed S, Shearer DW. Evidence for Local Antibiotics in the Prevention of Infection in Orthopaedic Trauma. J Clin Med. 2022;11(24):7461. doi:10.3390/jcm11247461

    34. Morgenstern M, Vallejo A, McNally MA, et al. The effect of local antibiotic prophylaxis when treating open limb fractures: a systematic review and meta-analysis. Bone Joint Res. 2018;7(7):447–456. doi:10.1302/2046-3758.77.BJR-2018-0043.R1

    35. Craig J, Fuchs T, Jenks M, et al. Systematic review and meta-analysis of the additional benefit of local prophylactic antibiotic therapy for infection rates in open tibia fractures treated with intramedullary nailing. Int Orth. 2014;38(5):1025–1030. doi:10.1007/s00264-014-2293-2

    36. Major Extremity Trauma Research Consortium (METRC), et al. Effect of Intrawound Vancomycin Powder in Operatively Treated High-risk Tibia Fractures: a Randomized Clinical Trial. JAMA Surg. 2021;156(1):e207259. doi:10.1001/jamasurg.2020.7259

    37. Pesante BD, Parry JA. The Effect of Vancomycin and Tobramycin Local Antibiotic Powder on Surgical Site Infections After Open Treatment of Fracture: a Retrospective Propensity-Matched Analysis. J Orthop Trauma. 2024;38(4):177–182. doi:10.1097/BOT.0000000000002758

    38. Zuelzer DA, Hayes CB, Hautala GS, Akbar A, Mayer RR, Jacobs CA. Early Antibiotic Administration Is Associated with a Reduced Infection Risk When Combined with Primary Wound Closure in Patients with Open Tibia Fractures. Clin Orth Relat Res. 2021;479(3):613–619. doi:10.1097/CORR.0000000000001507

    39. Patzakis MJ, Wilkins J. Factors influencing infection rate in open fracture wounds. Clin Orthop Relat Res. 1989;243:36–40.

    40. Dellinger EP, Caplan ES, Weaver LD, et al. Duration of preventive antibiotic administration for open extremity fractures. Arch Surg. 1988;123(3):333–339. doi:10.1001/archsurg.1988.01400270067010

    41. British Orthopaedic Association Trauma Committee. British Association Standard for Trauma (BOAST): open fracture management Injury. 2020;51(2):174–177. doi:10.1016/j.injury.2020.06.005.

    42. Paley D, Herzenberg JE. Intramedullary infections treated with antibiotic cement rods: preliminary results in nine cases. J Orthop Trauma. 2002;16:723–729. doi:10.1097/00005131-200211000-00007

    43. Vargas-Hernandez JS, Sanchez CA, Renza S, Leal JA. Effectiveness of antibiotic-coated intramedullary nails for open tibia fracture infection prevention. A systematic review and meta-analysis. Injury. 2023;54(6):110857. doi:10.1016/j.injury.2023.110857

    44. De Meo D, Cannari FM, Petriello L, Persiani P, Villani C. Gentamicin-Coated Tibia Nail in Fractures and Nonunion to Reduce Fracture-Related Infections: a Systematic Review. Molecules. 2020;25(22):5471. doi:10.3390/molecules25225471

    45. Anglen JO. Wound irrigation in musculoskeletal injury. J Am Acad Orthop Surg. 2001;9(4):219–226. doi:10.5435/00124635-200107000-00001

    46. Heckmann ND, Davis JA, Mombell K, et al. Delayed debridement of open tibia fractures beyond 24 and 48 h does not appear to increase infection and reoperation risk. Europ J Orthop Surg Traumatol. 2022;32(5):953–958. doi:10.1007/s00590-021-03057-2

    47. Li J, Wang Q, Lu Y, et al. Relationship Between Time to Surgical Debridement and the Incidence of Infection in Patients with Open Tibial Fractures. Orthop Surg. 2020;12(2):524–532. doi:10.1111/os.12653

    48. Elniel AR, Giannoudis PV. Open fractures of the lower extremity: current management and clinical outcomes. EFFORT Open Rev. 2018;3(5):316–325. doi:10.1302/2058-5241.3.170072

    49. Kortram K, Bezstarosti H, Metsemakers WJ, Raschke MJ, Van Lieshout EMM, Verhofstad MHJ. Risk factors for infectious complications after open fractures; a systematic review and meta-analysis. Int Orth. 2017;41(10):1965–1982. doi:10.1007/s00264-017-3556-5

    50. Flow Investigators, Bhandari M, Jeray KJ, Petrisor BA, Devereaux PJ, Heels-Ansdell D. A Trial of Wound Irrigation in the Initial Management of Open Fracture Wounds. N Engl J Med. 2015;373(27):2629–2641. doi:10.1056/NEJMoa1508502

    51. Crowley DJ, Kanakaris NK, Giannoudis PV. Irrigation of the wounds in open fractures. J Bone Joint Br. 2007;89(5):580–585. doi:10.1302/0301-620X.89B5.19286

    52. Duyos OA, Beaton-Comulada D, Davila-Parilla A, et al. Management of Open Tibial Shaft Fractures: does the Timing of Surgery Affect Outcomes. J Am Acad Orthop Surg. 2017;25(3):230–238. doi:10.5435/JAAOS-D-16-00127

    53. Yokohama K, Itoman M, Uchino M, Fukushima K, Nitta H, Kojima Y. Immediate versus delayed intramedullary nailing for open fractures of the tibial shaft: a multivariate analysis of factors affecting deep infection and fracture healing. Indian J Orthop. 2008;42(4):410–419. doi:10.4103/0019-5413.43385

    54. Rajasekaran S. Early versus delayed closure of open fractures. Injury. 2007;38(8):890–895. doi:10.1016/j.injury.2007.01.013

    55. Moola FO, Carli A, Berry GK, Reindl R, Jacks D, Harvey EJ. Attempting primary closure for all open fractures: the effectiveness of an institutional protocol. Can J Surg. 2014;57(3):E82–88. doi:10.1503/cjs.011413

    56. Hohmann E, Tetsworth K, Radziejowski MJ, Wiesnieswki TF. Comparison of delayed and primary wound closure in the treatment of open tibial fractures. Arch Orthop Trauma Surg. 2007;127(2):131–136. doi:10.1007/s00402-006-0222-6

    57. Scharfenberger AV, Alabassi K, Smith S, et al. Primary Wound Closure After Open Fracture: a Prospective Cohort Study Examining Nonunion and Deep Infection. J Orthop Trauma. 2017;31(3):121–126. doi:10.1097/BOT.0000000000000751

    58. Riechelmann F, Kaiser P, Arora R. Primary soft tissue management in open fracture. Oper Orthop Traumatol. 2018;30(5):294–308. doi:10.1007/s00064-018-0562-8

    59. Reynolds AW, Garay M, Philp FH, Hammarstedt, Altman GT, Nwankwo CH. Definitive fixation of open tibia fractures: does reopening the traumatic wound increase complication rates? J Clin Orthop Trauma. 2021;24:101715. doi:10.1016/j.jcot.2021.101715

    60. Melvin JS, Dombroski DG, Torbert JT, Kovach SJ, Esterhai JL, Mehta S. Open tibial shaft fractures: i. Evaluation and initial wound management. J Am Acad Orthop Surg. 2010;18(1):10–19. doi:10.5435/00124635-201001000-00003

    61. Lack WD, Karunakar MA, Angerame MR, et al. Type III open tibia fractures: immediate antibiotic prophylaxis minimizes infection. J Orthop Trauma. 2015;29(1):1–6. doi:10.1097/BOT.0000000000000262

    62. Kim JH, Lee DH. Negative pressure wound therapy vs. conventional management in open tibia fractures: systematic review and meta-analysis. Injury. 2019;50(10):1764–1772. doi:10.1016/j.injury.2019.04.018

    63. Stannard JP, Volgas DA, Stewart R, McGwin G, Alonso JE. Negative pressure wound therapy after severe open fractures: a prospective randomized study. J Orthop Trauma. 2009;23(8):552–557. doi:10.1097/BOT.0b013e3181a2e2b6

    64. Kumaar A, Shanhappa AH, Ethiraj P. A Comparative Study on Efficacy of Negative Pressure Wound Therapy Versus Standard Wound Therapy for Patients With Compound Fractures in a Tertiary Care Hospital. Cureus. 2022;14(4):e23727. doi:10.7759/cureus.2372

    65. Costa ML, Achten J, Bruce J, et al. UK WOLLF Collaboration. Effect of Negative Pressure Wound Therapy vs Standard Wound Management on 12-Month Disability Among Adults With Severe Open Fracture of the Lower Limb: the WOLLF Randomized Clinical Trial. JAMA. 2018;319(22):2280–2288. doi:10.1001/jama.2018.6452

    66. Costa ML, Achten J, Knight R, Png ME, Bruce J, Dutton S. Negative-pressure wound therapy compared with standard dressings following surgical treatment of major trauma to the lower limb: the WHiST RCT. Health Technol Assess. 2020;38(1):1–86. doi:10.3310/hta24380

    67. Costa ML, Achten J, Knight R, Campolier M, MS M. Five-year outcomes for patients sustaining severe fractures of the lower limb from the Wound Healing in Surgery for Trauma (WHIST) trial. Bone Joint J. 2024;106(8):858–864. doi:10.1302/0301-620X.106B8

    68. Farhan-Alanie M, Ward J, Kelly MB, Al-Hourani K. Current Perspectives on the Management of Bone Fragments in Open Tibial Fractures: new Developments and Future Directions. Orthop Res Rev. 2022;14:275–286. doi:10.2147/ORR.S340534

    69. Al-Hourani K, Stoddard M, Khan U, Riddick A, Kelly M. Orthoplastic reconstruction of type IIIB open tibial fractures retaining debrided devitalized cortical segments: the Bristol experience 2014 to 2018. Bone Joint J. 2019;101(8):1002–1008. doi:10.1302/0301-620X.101B8.BJJ

    70. Bruce B, Sheibani-Rad S, Appleyard D, et al. Are dropped osteoarticular bone fragments safely reimplantable in vivo? J Bone Joint Surg Am. 2011;93(5):430–438. doi:10.2106/JBJS.J.00793

    71. Shanmuganathan R, Chandra Mohan AK, Agraharam D, Perumal R, Jayaramaraju D, Kulkarni S. Successful reimplantation of extruded long bone segments in open fractures of lower limb–a report of 3 cases. Injury. 2015;46(7):1389–1392. doi:10.1016/j.injury.2015.04.006

    72. Rathore S, Reddy IV, Kumar AHA. A novel technique for reimplanting extruded bone fragments in open fractures. Trauma Case Rep. 2016;4:5. doi:10.1016/j.tcr.2016.05.006

    Continue Reading

  • Women’s Super League: Minimum salaries introduced in WSL and WSL 2 this season

    Women’s Super League: Minimum salaries introduced in WSL and WSL 2 this season

    Minimum salaries for players in the top two tiers of professional women’s football in England are being introduced for the first time this season.

    It is one of the requirements brought in by WSL Football – the company overseeing England’s professional leagues.

    WSL Football would not disclose what the minimum level will be, but it is described as a “full-time wage”.

    It is expected the salary range will be made public when the updated WSL and WSL 2 regulations are published later this season.

    The salaries will be based on thresholds such as the age of players, what league they are playing in, and their experience in the game following consultation with the Professional Footballers’ Association (PFA).

    “We feel that’s a really positive move. We have so many players who have had to juggle part-time roles while playing football,” WSL Football’s chief operating officer Holly Murdoch told BBC Sport.

    “Being able to ensure all our players can earn a full-time wage from football is very, very important. I would say it’s the start as it’s a framework we can develop on.

    “We have worked really closely with the PFA on what those thresholds should look like. We will be reviewing that constantly.”

    On top of minimum salary requirements, clubs must meet increased criteria around high-performance environments.

    It comes after a multi-year partnership was agreed between WSL Football and Nike. Part of the agreement will see Nike provide football boots and goalkeeper gloves to all players in the WSL and WSL 2 who do not have an endorsement deal.

    There is also a new collaboration with external company Kyniska Advocacy – an athlete-led organisation aimed at evolving new standards for safeguarding.

    All players will gain access to their confidential support service as an independent route for raising welfare concerns.

    “We know that due to the fact the game has grown so rapidly, we have disparity. Part of that creates a competitive advantage, so there are elements we have to mandate,” added Murdoch.

    “One of the requirements will be to have a ‘performance wellbeing’ role. We will be asking all clubs to employ that role full-time by the end of this season.

    “We want to make sure we are preparing our players for life on the pitch, both mentally and physically, as well as off it. That role is critical.”

    The 2025-26 WSL season begins on Friday as champions Chelsea face Manchester City at Stamford Bridge, on the back of England winning a second consecutive European Championship title.

    Continue Reading

  • The first-ever smartwatches from Garmin with inReach technology for satellite and cellular connectivity

    The first-ever smartwatches from Garmin with inReach technology for satellite and cellular connectivity

    September 3, 2025

    Groundbreaking MicroLED model is the brightest smartwatch ever made

    OLATHE, Kan. (September 3, 2025) /ENDURANCE SPORTSWIRE/ – Garmin (NYSE: GRMN) is advancing the future of smartwatch technology with the introduction of fēnix® 8 Pro series. These premium GPS smartwatches are the first to feature inReach® technology for satellite and cellular connectivity1—letting athletes and adventurers leave their phone behind and still stay in touch. Further revolutionizing the smartwatch industry, fēnix 8 Pro – MicroLED introduces a first-of-its-kind, high-resolution MicroLED display for superior readability.

    “fēnix 8 Pro is changing the game for smartwatches. This new lineup is full of breakthrough innovations, bringing life-changing inReach technology to the wrist to help keep athletes and adventurers in touch with their family and friends and introducing the first-ever ultra-bright MicroLED display to a smartwatch so users can see their maps, stats, health and wellness metrics and more like never before.”

    —Susan Lyman, Garmin Vice President of Consumer Sales and Marketing

    Leave the phone behind and still stay connected

    Designed for those pursuits that make it impractical to carry a phone, fēnix 8 Pro has built-in inReach technology for satellite and cellular connectivity1.

    Satellite connectivity

    fēnix 8 Pro uses inReach technology to let explorers exchange messages and send location check-ins.

    • Text messages: Send and receive text messages with those using the Garmin Messenger app on their smartphone or compatible Garmin smartwatch.
    • Location check-ins: Send location updates to family and friends so they can keep track of trip progress.

    Cellular connectivity

    In addition to sending text messages or providing location check-ins, fēnix 8 Pro can be used to make phone calls, send voice messages, share LiveTrack links and view weather forecasts when connected to the LTE network.

    • Voice calls: Make and take voice calls from the watch with other fēnix 8 Pro users or those using the Garmin Messenger app on their smartphone.
    • Voice messages: Check in with family and friends by exchanging 30-second voice messages. Recipients can listen to the messages or read the transcriptions on their watch or in the Garmin Messenger app.
    • LiveTrack: Friends and family can follow the adventures with LiveTrack location sharing and location check-ins on their smartphone. Users can also alert their friends and family when a LiveTrack session has started, in case they want to follow along or reach out during an activity.
    • Weather forecasts: Access current weather conditions and multiday forecasts to stay prepared for what’s ahead.

    SOS capability supported by Garmin Response

    When an SOS is triggered, fēnix 8 Pro will send a message over satellite or cellular connectivity to the Garmin Response center, where a dedicated team of skilled emergency response coordinators are ready at any time. From there, Garmin Response will communicate with the user, their listed emergency contacts, search and rescue organizations and other available local resources. They provide updates to users and emergency contacts on the response effort, including confirmation when help is on the way, and remain available as the incident is being resolved. With nearly two decades of experience, the Garmin Response team has supported more than 17,000 inReach incident responses in more than 150 countries on all seven continents.

    First-of-its-kind MicroLED display

    Offering remarkable brightness in exquisite detail, fēnix 8 Pro – MicroLED features over 400,000 individual LEDs delivering up to 4,500 nits, making it the brightest smartwatch ever. The result is a revolutionary display that produces rich colors and high pixel densities with wide viewing angles and superior readability—even in direct sunlight.

    Rugged design, premium features

    Made for any adventure, all fēnix 8 Pro models are dive-rated and feature leakproof metal buttons, a metal sensor guard cover, AMOLED or MicroLED touchscreen displays and titanium bezels, plus an LED flashlight for greater visibility in dark environments.

    Built for wherever the adventure leads, fēnix 8 Pro is loaded with Garmin’s full suite of performance, navigation, health and wellness2, and connected features, including endurance score, hill score, daily suggested workouts, preloaded TopoActive Maps, dynamic round-trip routing, the Garmin ECG App3, sleep coach, Garmin Pay, safety and tracking features and more. To learn more, visit www.garmin.com.

    fēnix 8 Pro – AMOLED comes in 47mm and 51mm sizes, gets up to 27 days of battery life in smartwatch mode4 and starts at $1,199.99. fēnix 8 Pro – MicroLED comes in a 51mm size, gets up to 10 days of battery life in smartwatch mode and is $1,999.99. Both models are available to purchase on September 8, 2025.

    Engineered on the inside for life on the outside, Garmin products have revolutionized life for adventurers, athletes, off-road explorers, road warriors and outdoor enthusiasts everywhere. Committed to developing products that enhance experiences, enrich lives and help provide peace of mind, Garmin believes every day is an opportunity to innovate and a chance to beat yesterday. Visit the Garmin Newsroom, email our media team, connect with @garminoutdoor on social, or follow our blog.

    1 Active subscription required; LTE network coverage and satellite connectivity are not available in all countries. Check Garmin.com/fenix8ProCoverage to see which services are accessible in your area — or in countries to where you may be traveling; some jurisdictions regulate or prohibit the use of satellite communication devices. It is the responsibility of the user to know and follow all applicable laws in the jurisdictions where the device is intended to be used.

    2 Activity tracking accuracy.

    3 The ECG app is only available on select Garmin smartwatches with the latest version of the Garmin Connect smartphone app and watch software. The ECG app is not available in all regions; see Garmin.com/ECG for availability. The ECG app is only intended for adults aged 22 years and over. The ECG app is capable of recording an ECG similar to a Lead I ECG and detecting the presence of atrial fibrillation or normal sinus rhythm.

    4 Battery life estimate is for the 51mm fēnix 8 Pro – AMOLED

    ###

    About Garmin International, Inc. Garmin International, Inc. is a subsidiary of Garmin Ltd. (NYSE: GRMN). Garmin Ltd. is incorporated in Switzerland, and its principal subsidiaries are located in the United States, Taiwan and the United Kingdom. Garmin, fēnix and inReach are registered trademarks, Garmin Messenger and Garmin Pay are trademarks and Garmin Response is a service mark of Garmin Ltd. or its subsidiaries. All other brands, product names, company names, trademarks and service marks are the properties of their respective owners. All rights reserved.

    Notice on Forward-Looking Statements:

    This release includes forward-looking statements regarding Garmin Ltd. and its business. Such statements are based on management’s current expectations. The forward-looking events and circumstances discussed in this release may not occur and actual results could differ materially as a result of known and unknown risk factors and uncertainties affecting Garmin, including, but not limited to, the risk factors listed in the Annual Report on Form 10-K for the year ended December 28, 2024, filed by Garmin with the Securities and Exchange Commission (Commission file number 0-31983), and the Quarterly Report on Form 10-Q for the quarter ended June 28, 2025 filed by Garmin with the Securities and Exchange Commission (Commission file number 001-41118). Copies of such Form 10-K and Form 10-Q are available at https://www.garmin.com/en-US/investors/sec/. No forward-looking statement can be guaranteed. Forward-looking statements speak only as of the date on which they are made and Garmin undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

    MEDIA CONTACTS

    Stephanie Kelner and Natalie Miller
    913-397-8200
    media.relations@garmin.com


    Continue Reading

  • Victoria Beckham’s Foundation is Perfect for the Makeup Minimalist

    Victoria Beckham’s Foundation is Perfect for the Makeup Minimalist

    This insistence on breathability and real-skin finish explains why she landed on drops—featherlight, buildable, modern.

    The Foundation Drops joins a complexion line that already includes the Concealer Pen and extends Beckham’s existing collaboration of a serum and primer with stem cell scientist Professor Augustinus Bader and his eponymous skin-care line, which has become a defining feature of Victoria Beckham Beauty. “I like to partner with the best. For me, that is Professor Bader–I can’t compete with him, nor do I want to–I want to collaborate, and always with the best.”

    Courtesy of Victoria Beckham

    As with the rest of her complexion products, the Drops fuse makeup and treatment. At the heart is Bader’s proprietary TFC8 complex, transporting nutrients to skin cells to aid renewal, alongside echinacea extract to plump, spilanthes flower to smooth, and olive leaf extract to support barrier function. “I can do a self-care day but still wear my foundation,” Beckham says. “Because it is ultimately also treating the skin.”

    As a beauty director, I’m wary of hyperbole – but having worn the foundation myself, I can attest that it does what she says. The texture is remarkable: thin and fluid, but capable of being built into polished coverage. It looks less like makeup than like well-rested skin, surviving the heatwaves and rainstorms of our London summer and beyond.

    The Foundation Drops launches in 19 flexible shades, each designed with stretch to adapt across a wide spectrum of skin tones and undertones. Beckham likes to apply the foundation with her own brushes the launch of which, earlier this spring, was a subtle clue to devotees that a foundation was on the way–though she notes it can just as easily be pressed in with fingertips for a sheer finish.

    For Beckham, this launch is about more than product innovation–it’s about rewriting her own history with skin. “I have struggled with my skin my whole life… and I know how it feels not to feel confident. That’s why this product is so personal to me–I want other women to finally feel seen and understood.”

    She adds: “When I say it’s been a lifetime in the making, I mean it. I’ve worn makeup since I was far too young because I was so self-conscious about my acne–and I’ve been searching ever since for something that actually makes skin look and feel better. This is it.”

    Shop more of Vogue’s favorite Victoria Beckham Beauty products, below.

    Victoria Beckham Beauty

    Portofino ’97 Eau de Parfum

    Victoria Beckham Beauty

    Reflect Highlighter Stick

    Continue Reading

  • MVA-BN Vaccine Still Protects Against Severe Mpox, But Boosters and Equity Challenges Remain

    MVA-BN Vaccine Still Protects Against Severe Mpox, But Boosters and Equity Challenges Remain

    A new retrospective cohort study published in The Lancet Primary Care has provided compelling real-world evidence that the MVA-BN (Modified Vaccinia Ankara-Bavarian Nordic) vaccine continues to offer substantial protection against severe monkeypox (mpox) disease more than 1.5 years after immunization. The commentary accompanying the study—written by infectious disease experts Dr. Emily Evans and Dr. Boghuma Titanji of Emory University—highlights how the findings mark a significant step forward in understanding vaccine durability and clinical protection in the face of waning antibody levels.

    The original research, conducted in New South Wales (NSW), Australia, by Latham et al., represents the largest and most detailed clinical study to date on breakthrough mpox infections in fully vaccinated individuals. It is particularly significant given the limited baseline immunity in the Australian population due to the absence of historical smallpox vaccination campaigns, a contrast to settings in Europe, North America, and parts of Africa.

    Durable Protection Despite Waning Antibodies

    The study included 674 confirmed mpox cases between June and November 2024, during Australia’s largest recorded mpox outbreak. Of those, 251 individuals (37%) were fully vaccinated with two doses of MVA-BN. The median interval between the second dose and symptom onset was nearly 22 months.

    Key outcomes demonstrate that full vaccination was associated with:

    • 89% reduced risk of hospitalization compared to unvaccinated individuals (RR 0.11; 95% CI 0.03–0.43),
    • 55% reduction in risk of systemic symptoms like fever, headache, and muscle pain (RR 0.72),
    • Significant reduction in extragenital lesions, a potential driver of casual-contact transmission (RR 0.45).

    Interestingly, fully vaccinated individuals were slightly more likely to present with anogenital lesions, though these were generally mild and did not lead to hospitalization.

    Despite laboratory evidence that antibody titers wane within 5–7 months of vaccination, these clinical findings suggest meaningful protection persists well beyond serological decline. This divergence between antibody kinetics and real-world outcomes adds nuance to the discussion around correlates of protection and vaccine-induced immunity.

    Implications for HIV-Positive Individuals

    While the Australian cohort included people living with HIV, the study did not stratify clinical outcomes by HIV status. This is a notable omission, given that HIV-positive individuals—especially those with advanced disease—are at substantially higher risk of severe mpox, including disseminated and even fatal outcomes.

    Previous research has shown that while people with HIV can mount adequate immune responses to MVA-BN, those with lower CD4 counts or poorly managed HIV may have weaker protection. In one clinical trial, antibody titers were significantly higher in people without HIV compared to those with HIV, despite both groups reaching high seropositivity rates.

    The absence of outcome data stratified by HIV status represents a critical gap, especially as current mpox outbreaks in sub-Saharan Africa—where HIV prevalence is high—continue to intensify.

    A Public Health Opportunity and National Imperative

    The findings have important implications for both national and global health security. Infections with mpox, while relatively rare outside high-risk populations, can escalate quickly during outbreaks and impose significant strain on healthcare systems.

    Preventing hospitalizations and systemic symptoms—especially in younger, unvaccinated populations—is not only a clinical goal but also a matter of public health resilience. In the Australian outbreak, the vast majority of mpox patients were men under 50, underscoring the vulnerability of generations never immunized against smallpox.

    As Dr. Titanji and Dr. Evans note, leveraging sexual health clinics as vaccination hubs has proven effective, but disparities in access persist. Populations disconnected from such services may face increased risk during future outbreaks, further emphasizing the need for broader, community-engaged vaccination strategies.

    Global Equity and the Next Phase: Boosters?

    The NSW study’s implication that protection extends well beyond the initial year is reassuring—but it also raises new questions. Should a third (booster) dose be recommended for specific populations? Should HIV-positive individuals, or those with high behavioral exposure risk, receive tailored vaccine schedules?

    The commentary urges global immunization technical advisory groups to incorporate these findings into deliberations about MVA-BN booster strategies. It also reinforces the call for equitable global access to MVA-BN, especially in lower-income settings currently grappling with resurging outbreaks.

    Notably, viral sequencing in the Australian outbreak revealed no substantial genetic divergence between viruses infecting vaccinated and unvaccinated individuals. This suggests vaccine escape was not a major factor in breakthrough infections and bolsters confidence in the ongoing relevance of the MVA-BN platform.

    Next Steps: Research, Policy:

    This evidence base provides a firm foundation for future preparedness—but several priorities remain:

    • Stratified clinical studies on vaccine efficacy in immunocompromised populations,
    • Longitudinal analyses of immune response durability post-MVA-BN,
    • Global coordination on vaccination campaigns in areas with rising case counts and high HIV prevalence,
    • Booster dose policy frameworks informed by risk profiling, not just time since vaccination.

    As mpox transitions from a global health emergency to an endemic risk, the world must shift from reactive containment to proactive, equitable protection—particularly for communities historically underserved by immunization programs.


    Sources and Further Reading

    Evans EE, Titanji BK. Protection that lasts? MVA-BN against clade IIb mpox. The Lancet Primary Care, 24 July 2025.

    Latham NH, Pett J, Katelaris AL, et al.  Clinical features of mpox in fully vaccinated people in New South Wales, Australia: a retrospective cohort study. The Lancet Primary Care, 24 July 2025.

    Taha AM, Rodriguez-Morales AJ, Sah R. Mpox breakthrough infections: concerns and actions. The Lancet Infectious Diseases, Nov 2023.

    Valentina M, Guiulia M, Eleonora C, et al. Humoral and T-Cell Responses Following MVA-BN Booster Vaccination Against Mpox Virus Clades Ib and IIb,  MedRxiv pre-print, 7 July 2025.

    Continue Reading

  • Desiree Miller’s Rugby World Cup Diary

    Desiree Miller’s Rugby World Cup Diary

    Writing this on the bus ahead of a six-hour trip from York to Brighton, it’s given me an opportunity to reflect on what an awesome past three weeks it’s been so far in England.

    To look forward though we must look back, and what a crazy game to be involved in last weekend against the USA. It brought out the best in both sides and we knew going into the game it wasn’t going to be easy with the Americans on the improve in the XVs space.

    We’ve had some great battles with them the past two years and the match in York had every twist and turn possible. Listening to people after the game they were commenting on how awesome the game was.

    For us we take our lessons away from the fact we could’ve won that game but our discipline cost us, particularly in the second half. It just felt like no matter how far we hit the front on the scoreboard the Americans would find a way to strike back and vice versa.

    For me being at my first World Cup I have been loving the journey so far, it’s everything I imagined it to be. As someone who came into rugby late, to be at the biggest stage of them all now has been surreal and I’m enjoying the rapid journey representing my country.

    It is always good to score a couple of tries but my teammates next to me are the reason I’m getting over the line as much as I am too. Caitlyn Halse is an outstanding teenager coming through and she is putting me into some space, while those next to her are all contributing as well.

    It was also nice to see the support we had in York for a sell-out fixture in the region. The stadium was deafening at times and after the game it’s always nice to be able to say thank you. We noticed there were a lot of English fans or general supporters cheering us on, so it made the atmosphere electric.

    We’ve also been welcomed into the north of England so kindly. From when we arrived in Manchester, through to the hospitality at our hotels and training facilities and match venues, it’s made it feel exactly like a world-class tournament.

    Off the field we’ve also been able to get out and explore some of the cities. Lori Cramer is our social butterfly on tour and given her previous playing experience in England we’ve very much been following her lead which has included a scavenger hunt around Manchester and a Wicked singalong experience.

    I can confirm that she has her fish flops around but generally keeps them limited to around the hotel or at training sessions, you are unlikely to see them at a game.

    I also went along to The Hundred cricket in my first week and caught up with Australian cricketer Phoebe Litchfield, who we did some cross-promo with before we left for the World Cup in July. Beth Mooney presented our jerseys against Samoa, bringing a real Aussie sporting flavour to our campaign.

    In York I headed along to the Jorvik Viking centre to learn about the city’s rich history, while others went to the York Dungeon, with a few still alive to tell the tale I hear.

    Our attention though now turns to Brighton and it’s a game we’ve been looking forward to for a while. I made my debut against England during WXV 1 in 2023 and it’s a game I’ll never forget. To be able to play the Red Roses, the host nation of a Rugby World Cup and No.1 ranked team in the world, is truly an honour. You want to play against the best to learn to beat the best and from our matches moving forward we know it is a challenging roadmap to the final.

    I am no mathematician but there are a few scenarios that can play out this weekend that will determine whether we’re in the quarter-finals or not in 2025. Firstly, we want to try and win the game, and the second otherwise is scoring at least four tries for a bonus point.

    If not, it will come down to our for-and-against alongside the USA, who we drew with last week. It sets up an exciting ending for the fans, and our advantage is we’ll know our targets before we run out onto the field. The result can still be in our control, which is the main thing. If we limit the Red Roses as much as possible and put points on the board it will go a long way to us advancing.

    The thought that there will be over 30,000 at our game blows my mind. They might not all be cheering for us but it’s truly a great showing of the impact the tournament is having in England. We will need to contain that element of the game as well, but as an athlete it’s what you live for, to play in big matches against the world’s best.

    Whether you’re going to be at the game, tuning in or supporting from afar, it should be a great occasion and arguably one of the biggest games of our lives on Saturday night.

    See you there!

    Desiree

    Continue Reading

  • New models track vegetation shifts in China’s lakes

    New models track vegetation shifts in China’s lakes

    Validation of AV coverage in Lake Taihu using the Sentinel-based model.

    GA, UNITED STATES, September 3, 2025 /EINPresswire.com/ — A new study presents satellite pixel-scale estimation models for aquatic vegetation coverage in lakes, addressing long-standing challenges in ecological monitoring. By integrating Unmanned Aerial Vehicle (UAV), Sentinel-2, and Landsat-8 imagery, the researchers developed a scalable, accurate method to quantify aquatic vegetation coverage and area. These models offer a powerful tool for long-term analysis of lake ecosystem dynamics and carbon sink assessments, with applications ranging from regional water management to global climate models.

    Aquatic vegetation plays a vital role in sustaining lake ecosystems, contributing to carbon storage, water purification, and biodiversity. While excessive vegetation can harm biodiversity by reducing light penetration, moderate coverage supports ecological balance. Accurate monitoring of aquatic vegetation area and density is therefore crucial for managing water resources and understanding lake ecosystem health. Traditional satellite-based methods have relied on binary classifications that merely detect presence or absence within a pixel, making it difficult to assess fractional coverage precisely. Based on these challenges, there is a pressing need to develop models that can accurately quantify aquatic vegetation coverage at the pixel level using satellite remote sensing data.

    Researchers from the Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences, published a study (DOI: 10.34133/remotesensing.0616) on April 30, 2025, in Journal of Remote Sensing that introduces a stepwise upscaling method for quantifying aquatic vegetation (AV) coverage in lakes. By leveraging Unmanned Aerial Vehicle (UAV), Sentinel-2 Multispectral Instrument (MSI), and Landsat 8 Operational Land Imager (OLI) imagery, they constructed the first satellite pixel-scale models capable of estimating both aquatic vegetation area and fractional coverage. This development addresses critical challenges in monitoring ecological changes across large lake systems, offering new capabilities for long-term vegetation tracking and environmental assessment.

    The team developed two novel models—one based on Sentinel-2 and the other on Landsat-8—achieving high accuracy in estimating aquatic vegetation coverage at the satellite pixel scale. The models were developed using a stepwise upscaling method. UAV images captured at 3-cm resolution provided fine-scale vegetation classification via the visible difference vegetation index (VDVI). These data were aligned with Sentinel-2 Multispectral Instrument (MSI) imagery to create a training set, followed by an intermediate Sentinel-based model. Using that model, resampled pixel-level vegetation maps were aligned with Landsat-8 imagery to train a second model. Both models used XGBoost for regression and were evaluated using R², Root Mean Square Error (RMSE), and Mean Absolute Error (MAE) to ensure performance and robustness. The Sentinel-based model, validated with UAV-derived data, achieved an R² of 0.95, while the Landsat-based model, built upon Sentinel data, reached an R² of 0.97.

    These models were used to map the vegetation dynamics of 42 large lakes in China’s Yangtze and Huai River basins over three decades. In 2022 alone, the total aquatic vegetation area reached 4,896.4 km², with notable differences in trends: increasing in the Yangtze region and decreasing in the Huai River basin. This pixel-level approach improves precision in ecosystem carbon stock assessment and offers a scalable monitoring framework for global lakes.

    “Our work bridges the gap between ground-based small-scale sampling and satellite large-scale observations, offering a scalable, high-accuracy solution for ecosystem monitoring,” said lead researcher Dr. Juhua Luo. “By capturing fractional vegetation coverage at the pixel level, we can support better carbon stock estimates and long-term aquatic ecological studies. This opens new avenues for maintaining aquatic ecosystem stability and health in the face of climate.”

    This research lays the groundwork for global-scale, pixel-level mapping of aquatic vegetation using freely available satellite data. The methodology supports integration into carbon budgeting models and lake ecosystem management frameworks. In the future, these models may be extended to estimate aquatic vegetation biomass and lake CO₂ fluxes, helping to track lake carbon sequestration capacity. Continued development could include anti-saturation aquatic vegetation indices and refined models for low and high vegetation density zones. With rising ecological threats, such tools are essential for timely, science-based intervention and restoration planning.

    DOI
    10.34133/remotesensing.0616

    Original Source URL
    https://doi.org/10.34133/remotesensing.0616

    Funding information
    This study was supported by the National Natural Science Foundation of China (42271377, 42271114) and by Science and Technology Planning Project of NIGLAS (NIGLAS2022GS09).

    Lucy Wang
    BioDesign Research
    email us here

    Legal Disclaimer:

    EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
    for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
    article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

    Continue Reading

  • Fred Vasseur on 5am starts, the pressure of Ferrari and getting the best out of Hamilton and Leclerc

    Fred Vasseur on 5am starts, the pressure of Ferrari and getting the best out of Hamilton and Leclerc

    Fred Vasseur leads Formula 1’s most storied team. At the Italian Grand Prix at Monza, the Tifosi – Ferrari’s passionate fans – want to see Charles Leclerc or Lewis Hamilton on the podium.

    But what they, the rest of Italy and Ferrari fans all over the world really want Vasseur to deliver is the Formula 1 World Championship.

    On this week’s episode of F1’s Beyond The Grid podcast, Vasseur tells host Tom Clarkson how Ferrari are building a team to fight for titles, and the high-priority objectives of his high-pressure job: getting the best out of Leclerc, and supporting Hamilton as he continues to adapt to Ferrari – the challenge of which Vasseur says may have been underestimated.

    He talks about his 5am starts in search of success, and why returning Ferrari to the top of the sport will take time – even with two proven stars in the cars.

    To listen to this week’s episode, simply hit go on the audio player above or click here to listen via your preferred podcasting platform.

    You can also check out a huge selection of previous episodes – spanning every decade of F1 – in our dedicated Beyond The Grid library here.

    Continue Reading

  • Six killed in attack on passenger vehicle in Kurram district

    Six killed in attack on passenger vehicle in Kurram district

    At least six people were killed when unidentified gunmen opened fire on a passenger vehicle in Khyber Pakhtunkhwa’s Kurram district.

    Police said the assailants targeted the vehicle with automatic weapons in Ahmad Khan Kallay area of Lower Kurram while it was en route from Para Chamkani to Sadda. The bodies of the victims were shifted to a nearby hospital.

    The attackers managed to flee, but a search operation was launched soon after the incident. Regional Police Officer Kohat Abbas Majid Marwat confirmed the deaths and said 12 suspects had been detained and weapons recovered during the operation.

    Heavy contingents of police and security forces are conducting house-to-house searches in the area. Authorities vowed that terrorists would not be spared and that peace in the region would be maintained.

    Kurram has witnessed repeated bouts of tribal violence, mostly linked to decades-old land disputes that claimed more than 130 lives last year.

    After months of clashes, rival tribes reached a ceasefire in January, followed by a year-long peace accord signed in July between the Lower Kurram and Sadda tribes.


    Continue Reading